Volume 27, Issue 148 (5-2017)                   J Mazandaran Univ Med Sci 2017, 27(148): 161-175 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Golchin A, Niknejad H. Cell Therapy Using Embryonic Stem Cell Source in Clinical Trial Studies: Advantages and Limitations. J Mazandaran Univ Med Sci 2017; 27 (148) :161-175
URL: http://jmums.mazums.ac.ir/article-1-9960-en.html
Abstract:   (6833 Views)

Background and purpose: The unique characteristics and potency of stem cells have attracted interest for their use in cell therapy. However, the use of these cells has some limitations and problems such as ethical issues. The aim of this study was to perform a systematic review on the use of embryonic stem cell for clinical therapy targets and investigating its advantages and limitations.

Materials and methods: Data was collected from electronic databases including PubMed, Science direct, Medline, Clinical trial.gov, SID, etc. The search keywords included pluripotent stem cell, Embryonic stem cell (eSC), and stem cell therapy.

Results: Study of published articles and ongoing studies showed that pluripotency, cell viability and low immunogenicity of eSC are amongst the major reasons for their use.

Conclusion: Recent developments in clinical application of eSC make them a major candidate in using stem cells alongside MSC and iPS. But, further studies are needed due to its importance in many aspects.  

Full-Text [PDF 379 kb]   (3847 Downloads)    
Type of Study: Review |

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Journal of Mazandaran University of Medical Sciences

Designed & Developed by : Yektaweb